Appropriate Use Criteria for ¹⁸F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease

This publication has 99 references indexed in Scilit:

• Positron Emission Tomography for Assessing Local Failure After Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
• What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis
  European Journal of Nuclear Medicine and Molecular Imaging, 2011
• Hallmarks of Cancer: The Next Generation
  Cell, 2011
• Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysis
  JNCI: Journal of the National Cancer Institute, 2010
• Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis
  Journal of Magnetic Resonance Imaging, 2009
• 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation
  European Journal of Cancer, 2009
• [F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults
  Cancer, 2009
• The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings
  Journal of Gastrointestinal Surgery, 2007
• Staging non-small cell lung cancer
  Cancer Imaging, 2007
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI: Journal of the National Cancer Institute, 2000